These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3797619)

  • 21. Disabling obsessive thoughts responsive to antidepressants.
    Jenike MA; Armentano ME; Baer L
    J Clin Psychopharmacol; 1987 Feb; 7(1):33-5. PubMed ID: 3818991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatments of autism, attention deficit hyperactivity disorder, oppositional defiant disorder, and depression in children and youth--commentary.
    Werry JS
    J Clin Child Psychol; 2001 Mar; 30(1):110-3. PubMed ID: 11294068
    [No Abstract]   [Full Text] [Related]  

  • 23. Anxiety disorders and obsessive compulsive disorder.
    Liebowitz MR
    Neuropsychobiology; 1998; 37(2):69-71. PubMed ID: 9566268
    [No Abstract]   [Full Text] [Related]  

  • 24. Clomipramine for comorbid conditions.
    Wilens TE; Steingard R; Biederman J
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):171. PubMed ID: 1537774
    [No Abstract]   [Full Text] [Related]  

  • 25. Psychopharmacologic treatment of obsessive-compulsive disorder.
    Thorneloe WF
    J Med Assoc Ga; 1988 Nov; 77(11):825-6. PubMed ID: 3057098
    [No Abstract]   [Full Text] [Related]  

  • 26. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.
    Correll CU; Kratochvil CJ; March JS
    J Clin Psychiatry; 2011 May; 72(5):655-70. PubMed ID: 21658348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
    Schaller JL; Behar D; Chamberlain T
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
    [No Abstract]   [Full Text] [Related]  

  • 28. Attention-deficit hyperactivity disorder and brain-derived neurotrophic factor: a speculative hypothesis.
    Tsai SJ
    Med Hypotheses; 2003 Jun; 60(6):849-51. PubMed ID: 12699711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder.
    Coric V; Milanovic S; Wasylink S; Patel P; Malison R; Krystal JH
    Psychopharmacology (Berl); 2003 May; 167(2):219-20. PubMed ID: 12658528
    [No Abstract]   [Full Text] [Related]  

  • 30. Clomipramine side effects.
    Cruz R
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1168-9. PubMed ID: 1429426
    [No Abstract]   [Full Text] [Related]  

  • 31. Intractable obsessive-compulsive disorder: comorbidity with unrecognized adult attention-deficit hyperactivity disorder?
    van der Feltz-Cornelis CM
    J Nerv Ment Dis; 1999 Apr; 187(4):243-5. PubMed ID: 10221558
    [No Abstract]   [Full Text] [Related]  

  • 32. Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment.
    Gürkan K; Bilgiç A; Türkoglu S; Kiliç BG; Aysev A; Uslu R
    J Psychopharmacol; 2010 Dec; 24(12):1810-8. PubMed ID: 19939861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tricyclic antidepressive agents in compulsive neuroses].
    Lingjaerde O
    Tidsskr Nor Laegeforen; 1968 Jun; 88(11):1040-2. PubMed ID: 5685764
    [No Abstract]   [Full Text] [Related]  

  • 34. Coexisting major depression and obsessive-compulsive disorder treated with venlafaxine.
    Zajecka JM; Fawcett J; Guy C
    J Clin Psychopharmacol; 1990 Apr; 10(2):152-3. PubMed ID: 2341595
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug treatment of compulsive disorder].
    Rapoport JL
    Nervenarzt; 1991 May; 62(5):318-20. PubMed ID: 1865964
    [No Abstract]   [Full Text] [Related]  

  • 36. [The role of drugs in the treatment of obsessive-compulsive disorders].
    den Boer JA; Westenberg HG
    Ned Tijdschr Geneeskd; 1990 Mar; 134(10):503-4. PubMed ID: 2107405
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].
    Rollini M; Baud P
    Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric clonidine poisoning as a result of pharmacy compounding error.
    Suchard JR; Graeme KA
    Pediatr Emerg Care; 2002 Aug; 18(4):295-6. PubMed ID: 12187137
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of obsessive-compulsive disorder.
    Veale D
    Br J Hosp Med; 1990 Apr; 43(4):278-81. PubMed ID: 2189520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antidepressive agents in non-depressive disorders].
    Peyré F
    Rev Prat; 1994 Nov; 44(17):2299-301. PubMed ID: 7984935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.